UBS Group’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.7K | Sell |
62,000
-44,021
| -42% | -$46.7K | ﹤0.01% | 6282 |
|
|
2025
Q1 | $144K | Sell |
106,021
-64,271
| -38% | -$87.4K | ﹤0.01% | 5516 |
|
|
2024
Q4 | $235K | Buy |
+170,292
| New | +$235K | ﹤0.01% | 5164 |
|
|
2024
Q3 | – | Sell |
-17,483
| Closed | -$37.6K | – | 8251 |
|
|
2024
Q2 | $37.6K | Sell |
17,483
-2,091
| -11% | -$4.5K | ﹤0.01% | 5756 |
|
|
2024
Q1 | $63.6K | Buy |
+19,574
| New | +$63.6K | ﹤0.01% | 5248 |
|
|
2023
Q4 | – | Sell |
-41,046
| Closed | -$660K | – | 8044 |
|
|
2023
Q3 | $660K | Sell |
41,046
-8,627
| -17% | -$139K | ﹤0.01% | 3408 |
|
|
2023
Q2 | $422K | Sell |
49,673
-2,552
| -5% | -$21.7K | ﹤0.01% | 3960 |
|
|
2023
Q1 | $515K | Buy |
52,225
+770
| +1% | +$7.6K | ﹤0.01% | 3680 |
|
|
2022
Q4 | $490K | Buy |
51,455
+22,348
| +77% | +$213K | ﹤0.01% | 3714 |
|
|
2022
Q3 | $506K | Sell |
29,107
-19,260
| -40% | -$335K | ﹤0.01% | 3360 |
|
|
2022
Q2 | $375K | Buy |
48,367
+47,209
| +4,077% | +$366K | ﹤0.01% | 3542 |
|
|
2022
Q1 | $17K | Buy |
+1,158
| New | +$17K | ﹤0.01% | 6587 |
|